mRNA vaccines represent a groundbreaking shift in vaccine technology by utilizing the body’s own cells to produce viral proteins, streamlining the manufacturing process. The potential of this approach is immense, as it not only reduces production time and costs but also enhances vaccine efficacy. Noubar's vision for Moderna emphasizes the importance of balancing risk and innovation to achieve ambitious goals in drug development.
